Relationship between the expression of telomerase and human papillomavirus infection in invasive uterine cervical carcinoma

Abstract

Telomerase activity was examined in invasive cervical carcinoma to assess whether it is activated during cervical malignant transformation and to look for its possible association with human papillomavirus (HPV) infection. Histologically confirmed invasive cervical carcinomas and benign cervices were assayed for telomerase activity by using a modified telomere repeat amplification protocol (TRAP). The same cases were subjected to polymerase chain reaction (PCR) detection of HPV by using consensus primers and type-specific (HPV types 16 and 18) primers. Telomerase activity was detected in 40 of 45 (88.9%) invasive cervical carcinomas and 2 (all chronic cervicitis) of 50 (4%) benign cervical lesions. HPV was detected in 36 (24 HPV-16 and 4 HPV-18 cases) of 45 (80%) invasive cervical carcinomas and 20 (11 HPV-16 and 1 HPV-18 cases) of 50 (40%) benign cervical changes. There was a significant correlation between the expression of telomerase with histological grade (ω=0.44, P<0.005), but no correlation was found between telomerase expression and HPV-18 (P>0.05). Although larger sample studies are needed, there seems to be a clear association between telomerase upregulation and HPV status, mainly HPV-16 infection.

Keywords

cervical neoplasms / telomerase / human papillomavirus

References

[1] McMurrayH. R., NguyenD., WestbrookT. F., et al.. Biology of human papillomaviruses. Int J Exp Pathol, 2001, 82(1): 15-33

[2] MunozN., BoschF. X., de SanjoseS., et al.. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med, 2003, 348(6): 518-527

[3] zur HausenH.. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer, 2002, 2(5): 342-350

[4] BisoffiM., HeaphyC. M., GriffithJ. K.. Telomeres: prognostic markers for solid tumors. Int J Cancer, 2006, 119(10): 2255-2260

[5] LiuJ. P.. Studies of the molecular mechanisms in the regulation of telomerase activity. FASEB J, 1999, 13(15): 2091

[6] BosserhoffA. K., GlablA., StolzW., et al.. Detection of telomerase activity in skin, melanocytic nevi and melanoma by telomerase PCR ELISA. Biochemica, 1997, 3: 16-18

[7] ZhengP. S., IwasakaT., YokoyamaM., et al.. Telomerase activation in in vitro and in vivo cervical carcinogenesis. Gynecol Oncol, 1997, 66(2): 222-226

[8] HiyamaE., GollahonL., KataokaT., et al.. Telomerase activity in human breast tumors. J Natl Cancer Inst, 1996, 88(2): 116-122

[9] MeiselsA., FortinR.. Condylomatous lesions of the cervix and vagina. I. Cytologic patterns. Acta Cytol, 1976, 20(6): 505-509

[10] MunozN., BoschF. X.. LaceyC.. Current views on the epidemiology of HPV and cervical cancer. Papillomavirus reviews: current research on papillomaviruses, 1996, Leeds, Leeds University Press: 227-237

[11] TsezouA., OikonomouP., KolliaP., et al.. The Role of Human Telomerase Catalytic Subunit mRNA Expression in Cervical Dysplasias. Exp Biol Med, 2005, 230(4): 263-270

[12] NairP., JayaprakashP. G., NairM. K., et al.. Telomerase, p53 and human papillomavirus infection in the uterine cervix. Acta Oncol, 2000, 39(1): 65-70

[13] HiroyukiF., MinoruI.. Human Papilloma Virus (HPV) and cervical cancer. J Med Invest, 2002, 49(3–4): 24-133

[14] WismanG. B., HollemaH., de JongS., et al.. Telomerase activity as a biomarker for (pre) neoplastic cervical disease in scrapings and frozen sections from patients with abnormal cervical smear. J Clin Oncol, 1998, 16(6): 2238

[15] YashimaK., AshfaqR., NowakJ., et al.. Telomerase activity and expression of its RNA component in cervical lesions. Cancer, 1998, 82(7): 1319-1327

[16] SudipS., VijayG. R., RandeepG., et al.. Telomerase—a potential molecular marker of lung and cervical cancer. Clin Chem Lab Med, 2002, 40(10): 994-1001

[17] SatoruM., CeciliaA. L., SalvadorL. V., et al.. The Role of Human Papilloma Virus in the Molecular Biology of Cervical Carcinogenesis. Kobe J Med Sci, 2004, 50(1): 9-19